Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Nasdaq Biotechnology Ishares ETF (IBB)

Nasdaq Biotechnology Ishares ETF (IBB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 6,232,800,800
  • Market Capitalization, $K 6,373,041
  • Shares Outstanding, K 59,550
  • 60-Month Beta 1.38
  • Price/Earnings ttm 24.40
  • Annual Dividend & Yield 0.26 (0.25%)
  • Most Recent Dividend 0.055 on 03/25/20
  • Management Fee 0.47%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
92.15 +15.21%
on 03/16/20
121.86 -12.88%
on 03/05/20
-7.71 (-6.77%)
since 02/28/20
3-Month
92.15 +15.21%
on 03/16/20
123.92 -14.32%
on 02/19/20
-15.39 (-12.66%)
since 12/27/19
52-Week
92.15 +15.21%
on 03/16/20
123.92 -14.32%
on 02/19/20
-5.63 (-5.04%)
since 03/29/19

Most Recent Stories

More News
Coronavirus Scare Supports These Biotech ETFs & Stocks

Growing coronavirus concerns provide some support to these biotech ETFs and stocks amid a massive market sell-off.

IBB : 107.51 (+2.67%)
CNCR : 19.62 (+1.45%)
BBH : 126.91 (+2.28%)
ARKG : 31.03 (-1.05%)
AYTU : 1.7100 (-6.04%)
FTSV : 95.37 (+0.87%)
VIR : 34.30 (+0.76%)
IDNA : 26.46 (-0.15%)
CODX : 8.57 (-6.34%)
CNTG : 15.23 (-4.69%)
ETF Strategies to Play the Rising Virus-Induced Volatility

Try these ETF strategies to counter the renewed risk of the spread of coronavirus.

GLD : 152.74 (+0.32%)
XLP : 54.55 (+1.94%)
IBB : 107.51 (+2.67%)
VXX : 50.18 (-0.83%)
USMV : 54.32 (+1.25%)
BTAL : 25.81 (+1.37%)
VCLT : 97.77 (+1.30%)
VDC : 137.64 (+1.82%)
HDGE : 7.09 (+1.58%)
VIIX : 107.14 (+0.45%)
CLIX : 54.56 (+0.28%)
SPLB : 29.07 (+1.75%)
ONLN : 32.68 (-0.31%)
OGIG : 24.56 (+0.74%)
Emergency Fed Cut Less Effective: ETFs That Should Survive

Why the Fed's emergency rate cut failed to energize markets and why these ETFs should stay steady (gain or lose little) amid the current scenario.

XLK : 80.69 (+2.67%)
GLD : 152.74 (+0.32%)
XLP : 54.55 (+1.94%)
IBB : 107.51 (+2.67%)
IBUY : 40.66 (-0.12%)
XLRE : 31.09 (-0.38%)
FINX : 24.45 (+1.66%)
SPIP : 29.66 (+0.10%)
Stimulus Hopes Triumph Over Virus: 5 Top ETF Picks for March

These top-ranked ETFs could prove profitable for investors in the month of March.

HD : 192.12 (+0.82%)
AMZN : 1,947.98 (+2.52%)
XLF : 20.84 (-0.81%)
TSLA : 503.22 (-2.17%)
SPY : 256.81 (+1.34%)
IBB : 107.51 (+2.67%)
QQQ : 189.18 (+2.09%)
SOXX : 207.43 (+2.55%)
DIA : 217.90 (+0.72%)
VCR : 145.10 (-0.32%)
RPG : 99.81 (+0.50%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 45.73 (+1.55%)
JNJ : 130.31 (+5.81%)
LLY : 140.53 (+4.79%)
BMY : 54.43 (+3.11%)
IBB : 107.51 (+2.67%)
XBI : 76.92 (+1.26%)
ETFs to Play as Goldman Lowers US Q1 GDP Outlook

We discuss some ETF areas that investors can tap as aggravating coronavirus outbreak lead to a cut in U.S. GDP growth forecast.

NKE : 82.98 (-0.30%)
AAPL : 251.29 (+1.43%)
DIS : 94.88 (-1.58%)
IBB : 107.51 (+2.67%)
ICLN : 9.38 (-1.16%)
LQD : 124.17 (+1.42%)
TAN : 24.72 (-1.00%)
XBI : 76.92 (+1.26%)
BBH : 126.91 (+2.28%)
FBT : 128.99 (+1.22%)
VCIT : 86.46 (+0.71%)
AGG : 116.01 (+0.38%)
SPHQ : 29.90 (+1.63%)
QCLN : 19.61 (-1.85%)
BND : 86.43 (+0.43%)
Wanna Be a Value Investor? Follow Buffett & Play 2 ETF Areas

Warren Buffett took positions in Biogen and Kroger. Investors who want to follow Buffett's picking of these two value stocks can also play these ETFs as well.

BIIB : 311.36 (+4.92%)
AMZN : 1,947.98 (+2.52%)
WMT : 112.41 (+2.58%)
KR : 29.96 (+2.85%)
IBB : 107.51 (+2.67%)
BBH : 126.91 (+2.28%)
FTXD : 18.00 (-3.43%)
FXG : 39.56 (+0.84%)
IEIH : 25.02 (+3.22%)
Can Biotech ETFs Gain on Mixed Q4 Earnings Results?

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry, post their Q4 earnings releases.

BIIB : 311.36 (+4.92%)
ALXN : 85.89 (+2.24%)
GILD : 76.20 (+4.60%)
AMGN : 205.35 (+3.57%)
IBB : 107.51 (+2.67%)
XBI : 76.92 (+1.26%)
BBH : 126.91 (+2.28%)
FBT : 128.99 (+1.22%)
Diodes (DIOD) Q4 Earnings and Revenues Top Estimates

Diodes (DIOD) delivered earnings and revenue surprises of 3.17% and 0.39%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

BIIB : 311.36 (+4.92%)
ALXN : 85.89 (+2.24%)
GILD : 76.20 (+4.60%)
AMGN : 205.35 (+3.57%)
IBB : 107.51 (+2.67%)
XBI : 76.92 (+1.26%)
BBH : 126.91 (+2.28%)
FBT : 128.99 (+1.22%)
VAREX IMAGING (VREX) Q1 Earnings Miss Estimates

VAREX IMAGING (VREX) delivered earnings and revenue surprises of -25.00% and 4.87%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

BIIB : 311.36 (+4.92%)
ALXN : 85.89 (+2.24%)
GILD : 76.20 (+4.60%)
AMGN : 205.35 (+3.57%)
IBB : 107.51 (+2.67%)
XBI : 76.92 (+1.26%)
BBH : 126.91 (+2.28%)
FBT : 128.99 (+1.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade IBB with:

Fund Summary

The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology...

See More

Key Turning Points

2nd Resistance Point 108.82
1st Resistance Point 106.77
Last Price 107.76
1st Support Level 103.39
2nd Support Level 102.06

See More

52-Week High 123.92
Fibonacci 61.8% 111.78
Fibonacci 50% 108.04
Last Price 107.76
Fibonacci 38.2% 104.29
52-Week Low 92.15

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar